Cancer-Causing Proteins Asheville NC

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

Wieslawa Pekal, MD
(828) 253-4262
445 Biltmore Ave # S-100
Asheville, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Suny-Hlth Sci Ctr At Brooklyn, Coll Of Med, Brooklyn Ny 11203
Graduation Year: 1990
Hospital
Hospital: Haywood Reg Med Ctr, Clyde, Nc
Group Practice: Cancer Care Of Western North Carolina

Data Provided by:
Paul Langlie Martin, MD
(828) 254-2700
31 College Pl Ste B210
Asheville, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Washington Univ Sch Of Med, St Louis Mo 63110
Graduation Year: 1987

Data Provided by:
Krystal Dawn Sanchez, MD
50 Doctors Dr Ste 105
Asheville, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Univ Of Fl Coll Of Med, Gainesville Fl 32610
Graduation Year: 1989

Data Provided by:
Ronald Myron Friedman
(828) 253-4262
445 Biltmore Ave
Asheville, NC
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Quinten C Black
(828) 253-7077
445 Biltmore Ave
Asheville, NC
Specialty
Radiation Oncology

Data Provided by:
Mohan Chand Thakuri
(828) 253-4262
445 Biltmore Ave
Asheville, NC
Specialty
Hematology / Oncology

Data Provided by:
Jeffrey S Roberts
(828) 253-7077
445 Biltmore Ave
Asheville, NC
Specialty
Radiation Oncology

Data Provided by:
Christopher Haekang Chay
(828) 253-4262
445 Biltmore Ave
Asheville, NC
Specialty
Hematology / Oncology, Medical Oncology

Data Provided by:
Robert Carr Moffatt
(828) 258-2464
86 Victoria Rd
Asheville, NC
Specialty
Surgical Oncology

Data Provided by:
Michael Joseph Messino
(828) 253-4262
445 Biltmore Ave
Asheville, NC
Specialty
Medical Oncology

Data Provided by:
Data Provided by:

Cancer-Causing Proteins

Provided By:

Scientists are closer to understanding how a recently approved class of antibiotics may work against cancer.

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

The researchers also found that thiazoles may inhibit proteasomes, a molecular complex within cells that disposes of old proteins marked for destruction. Recently, a number of proteasome inhibitors have shown promise against cancer. One of these inhibitors, bortezomib (Velcade), has proven effective against a number of cancers, including myeloma and certain forms of lymphoma.

The new research, which appears in the online journal PLoS ONE, points to the possible anti-cancer use of thiazoles in the future. In a university news release, study author Andrei Gartel, an associate professor of molecular genetics, said that by using thiazole antibiotics in combination with well-known proteasome inhibitors, "we may see a synergy that allows us to markedly reduce the dose of any one of these drugs and still effectively kill the cancer cells."

More information

Read more about cancer treatments at the U.S. National Cancer Institute.

SOURCE: University of Illinois at Chicago, news release, Aug. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com